Free Trial

Sight Sciences (SGHT) Insider Trading & Ownership

Sight Sciences logo
$3.80 -0.06 (-1.55%)
(As of 11/15/2024 ET)

Sight Sciences (NASDAQ:SGHT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
28.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.45 M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$17.90 M
Get SGHT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sight Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SGHT Insider Buying and Selling by Quarter

Sight Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/21/2024Matthew LinkInsiderSell21,831$5.61$122,471.91  
10/18/2024Matthew LinkInsiderSell20,487$5.98$122,512.26  
10/16/2024Matthew LinkInsiderSell20,734$5.91$122,537.94  
10/2/2024David BadawiCTOSell3,167$5.99$18,970.33  
10/2/2024Paul BadawiCEOSell12,727$5.99$76,234.73  
10/1/2024Alison BauerleinCFOSell10,130$6.08$61,590.40  
10/1/2024Jeremy B HaydenInsiderSell4,878$6.08$29,658.24  
10/1/2024Sam Boong ParkCOOSell3,403$6.08$20,690.24  
7/2/2024Alison BauerleinCFOSell10,497$6.21$65,186.37  
7/2/2024Jeremy B HaydenInsiderSell5,055$6.21$31,391.55  
7/2/2024Sam Boong ParkCOOSell3,525$6.21$21,890.25  
7/1/2024David BadawiCTOSell3,128$6.42$20,081.76  
7/1/2024Paul BadawiCEOSell12,569$6.42$80,692.98  
5/17/2024Alison BauerleinCFOSell13,066$5.42$70,817.72  
4/3/2024Alison BauerleinCFOSell10,123$5.08$51,424.84  
4/3/2024David BadawiCTOSell3,128$5.08$15,890.24  
4/3/2024Jeremy B HaydenInsiderSell4,893$5.08$24,856.44  
4/3/2024Paul BadawiCEOSell12,571$5.08$63,860.68  
4/3/2024Sam Boong ParkCOOSell3,414$5.08$17,343.12  
1/17/2024David BadawiCTOSell3,414$5.16$17,616.24  
1/17/2024Jeremy B HaydenInsiderSell4,538$5.16$23,416.08  
1/17/2024Paul BadawiCEOSell15,917$5.16$82,131.72  
1/17/2024Sam Boong ParkCOOSell5,443$5.16$28,085.88  
12/27/2023D1 Capital Partners L.P.Major ShareholderSell2,852,036$5.86$16,712,930.96  
11/29/2023Staffan EncrantzDirectorBuy3,223$3.50$11,280.50  
11/27/2023Staffan EncrantzDirectorBuy246,331$3.31$815,355.61  
11/24/2023Staffan EncrantzDirectorBuy21,855$3.09$67,531.95  
11/22/2023Staffan EncrantzDirectorBuy41,085$2.50$102,712.50  
11/20/2023Staffan EncrantzDirectorBuy79,234$2.25$178,276.50  
11/17/2023Staffan EncrantzDirectorBuy126,664$2.19$277,394.16  
(Data available from 1/1/2013 forward)

SGHT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sight Sciences includes Alison Bauerlein, D1 Capital Partners L.P., David Badawi, Jeremy B Hayden, Jesse Selnick, Matthew Link, Paul Badawi, Sam Boong Park, and Staffan Encrantz. Learn more on insiders at SGHT.

28.90% of Sight Sciences stock is owned by insiders. Learn more on SGHT's insider holdings.

The following insider purchased SGHT shares in the last 24 months: Staffan Encrantz ($1,459,475.22).

Insiders have purchased a total of 521,854 SGHT shares in the last 24 months for a total of $1,459,475.22 bought.

The following insiders have sold SGHT shares in the last 24 months: Alison Bauerlein ($249,019.33), D1 Capital Partners L.P. ($16,712,930.96), David Badawi ($72,558.57), Jeremy B Hayden ($109,322.31), Matthew Link ($367,522.11), Paul Badawi ($302,920.11), and Sam Boong Park ($88,009.49).

Insiders have sold a total of 3,060,674 Sight Sciences shares in the last 24 months for a total of $17,902,282.88 sold.

Sight Sciences Key Executives

  • Mr. Paul Badawi (Age 49)
    Co-Founder, President, CEO & Director
    Compensation: $920.3k
    2 recent trades
  • Dr. David Badawi M.D. (Age 54)
    Founder, CTO & Director
  • Mr. Sam Boong Park (Age 63)
    Chief Operating Officer
    Compensation: $531.78k
    2 recent trades
  • Ms. Alison Perry Bauerlein (Age 43)
    CFO & Treasurer
  • Mr. Jeremy B. Hayden (Age 54)
    Chief Legal Officer
    2 recent trades
  • Mr. Steve R. Tamayo Jr.
    VP and Chief Ethics & Compliance Officer
  • Dr. Reay H. Brown
    Chief Medical Officer
  • Tom Huang
    Head of Corporate Strategy & Development
  • Mr. Matthew W. Link (Age 49)
    Chief Commercial Officer
    3 recent trades
  • Mr. Stephen B. Thau J.D.
    Secretary


This page (NASDAQ:SGHT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners